Navalign, LLC Boston Scientific Corp Transaction History

Navalign, LLC

$316 Million
Q2 2024

A detailed history of Navalign, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Navalign, LLC holds 12,429 shares of BSX stock, worth $1.05 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

12,429

Previous 12,449 0.16%

Holding current value

$1.05 Million

Previous $852,000 12.32%

% of portfolio

0.3%

Previous 0.28%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$67.33 - $77.71 $1,346 - $1,554	-20 Reduced 0.16%	12,429 $957,000
Q1 2024 Apr 12, 2024	SELL	$57.6 - $68.62 $21,542 - $25,663	-374 Reduced 2.92%	12,449 $852,000
Q4 2023 Jan 18, 2024	SELL	$48.64 - $57.81 $14,202 - $16,880	-292 Reduced 2.23%	12,823 $741,000
Q3 2023 Oct 10, 2023	SELL	$50.19 - $54.68 $24,593 - $26,793	-490 Reduced 3.6%	13,115 $692,000
Q2 2023 Jul 14, 2023	SELL	$49.72 - $54.64 $35,500 - $39,012	-714 Reduced 4.99%	13,605 $735,000
Q1 2023 Apr 19, 2023	SELL	$45.09 - $50.03 $13,031 - $14,458	-289 Reduced 1.98%	14,319 $716,000
Q4 2022 Feb 06, 2023	SELL	$39.56 - $47.22 $31,727 - $37,870	-802 Reduced 5.2%	14,608 $676,000
Q3 2022 Nov 02, 2022	BUY	$36.71 - $109.66 $22,613 - $67,550	616 Added 4.16%	15,410 $597,000
Q2 2022 Jul 27, 2022	SELL	$35.24 - $47.1 $845 - $1,130	-24 Reduced 0.16%	14,794 $551,000
Q1 2022 Apr 29, 2022	BUY	$40.9 - $45.1 $23,353 - $25,752	571 Added 4.01%	14,818 $638,000
Q4 2021 Feb 08, 2022	BUY	$38.07 - $44.87 $8,641 - $10,185	227 Added 1.62%	14,247 $605,000
Q3 2021 Nov 03, 2021	SELL	$41.23 - $45.88 $1,278 - $1,422	-31 Reduced 0.22%	14,020 $608,000
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $36,188 - $41,497	938 Added 7.15%	14,051 $601,000
Q1 2021 May 10, 2021	BUY	$35.27 - $39.67 $462,495 - $520,192	13,113 New	13,113 $507,000

Others Institutions Holding BSX

# of Institutions

1,450

Shares Held

1.21B

Call Options Held

8.14M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $121B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Navalign, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Navalign, LLC with notifications on news.

Account